Year |
Citation |
Score |
2023 |
Kingma J, Simard C, Drolet B. Overview of Cardiac Arrhythmias and Treatment Strategies. Pharmaceuticals (Basel, Switzerland). 16. PMID 37375791 DOI: 10.3390/ph16060844 |
0.453 |
|
2022 |
Pilote S, Simard C, Drolet B. Remdesivir (VEKLURY) for treating COVID-19: Guinea pig ex vivo and in vivo cardiac electrophysiological effects. Journal of Cardiovascular Pharmacology. PMID 35881906 DOI: 10.1097/FJC.0000000000001321 |
0.515 |
|
2021 |
Pilote S, Simard C, Drolet B. REMDESIVIR (VEKLURY) FOR TREATING COVID-19 PATIENTS: WHAT TO EXPECT FROM A CARDIAC ELECTROPHYSIOLOGICAL PERSPECTIVE Canadian Journal of Cardiology. 37: S44. DOI: 10.1016/j.cjca.2021.07.093 |
0.377 |
|
2019 |
Steinberg C, Pilote S, Simard C, Drolet B. The Scn5A Variant C683R Results In A Gain-Of-Function Of The Cardiac Sodium Current (Nav1.5) With Adrenergic Modulation Canadian Journal of Cardiology. 35. DOI: 10.1016/J.Cjca.2019.07.497 |
0.448 |
|
2017 |
Kingma JG, Simard D, Rouleau JR, Drolet B, Simard C. The Physiopathology of Cardiorenal Syndrome: A Review of the Potential Contributions of Inflammation. Journal of Cardiovascular Development and Disease. 4. PMID 29367550 DOI: 10.3390/Jcdd4040021 |
0.327 |
|
2017 |
Drolet B, Pilote S, Gélinas C, Kamaliza AD, Blais-Boilard A, Virgili J, Patoine D, Simard C. Altered Protein Expression of Cardiac CYP2J and Hepatic CYP2C, CYP4A, and CYP4F in a Mouse Model of Type II Diabetes-A Link in the Onset and Development of Cardiovascular Disease? Pharmaceutics. 9. PMID 29023376 DOI: 10.3390/Pharmaceutics9040044 |
0.405 |
|
2017 |
Pilote S, Simard C, Drolet B. Fingolimod (Gilenya ) in multiple sclerosis: bradycardia, atrioventricular blocks, and mild effect on the QTc interval. Something to do with the L-type calcium channel? Fundamental & Clinical Pharmacology. 31: 392-402. PMID 28299825 DOI: 10.1111/Fcp.12284 |
0.588 |
|
2015 |
Hasibu I, Patoine D, Pilote S, Drolet B, Simard C. The guinea-pig expresses functional CYP2C and P-glycoprotein: further validation of its usefulness in drug biotransformation/transport studies. Biopharmaceutics & Drug Disposition. 36: 183-203. PMID 25472529 DOI: 10.1002/Bdd.1931 |
0.323 |
|
2013 |
Kaddar N, Pilote S, Wong S, Bertr, Caillier, Patoine D, Drolet B, Simard C. Simultaneous Determination of Dofetilide and Amlodipine in Plasma by HPLC Journal of Chromatography & Separation Techniques. 4: 1-6. DOI: 10.4172/2157-7064.1000192 |
0.366 |
|
2012 |
Vigneault P, Pilote S, Patoine D, Simard C, Drolet B. Iloperidone (Fanapt®), a novel atypical antipsychotic, is a potent HERG blocker and delays cardiac ventricular repolarization at clinically relevant concentration. Pharmacological Research. 66: 60-5. PMID 22465688 DOI: 10.1016/J.Cjca.2011.07.193 |
0.783 |
|
2012 |
Vigneault P, Bourgault S, Kaddar N, Caillier B, Pilote S, Patoine D, Simard C, Drolet B. Galantamine (Reminyl) delays cardiac ventricular repolarization and prolongs the QT interval by blocking the HERG current. European Journal of Pharmacology. 681: 68-74. PMID 22366430 DOI: 10.1016/J.Ejphar.2012.02.002 |
0.783 |
|
2012 |
Caillier B, Pilote S, Patoine D, Levac X, Couture C, Daleau P, Simard C, Drolet B. Metabolic syndrome potentiates the cardiac action potential-prolonging action of drugs: a possible 'anti-proarrhythmic' role for amlodipine. Pharmacological Research. 65: 320-7. PMID 22154802 DOI: 10.1016/J.Phrs.2011.11.015 |
0.437 |
|
2012 |
Plante I, Vigneault P, Drolet B, Turgeon J. Rosuvastatin blocks hERG current and prolongs cardiac repolarization Journal of Pharmaceutical Sciences. 101: 868-878. PMID 22081364 DOI: 10.1002/Jps.22809 |
0.77 |
|
2012 |
Caillier B, Pilote S, Castonguay A, Patoine D, Ménard-Desrosiers V, Vigneault P, Hreiche R, Turgeon J, Daleau P, De Koninck Y, Simard C, Drolet B. QRS widening and QT prolongation under bupropion: a unique cardiac electrophysiological profile. Fundamental & Clinical Pharmacology. 26: 599-608. PMID 21623902 DOI: 10.1111/J.1472-8206.2011.00953.X |
0.743 |
|
2012 |
Kaddar N, Vigneault P, Pilote S, Patoine D, Simard C, Drolet B. Tizanidine (Zanaflex): A muscle relaxant that may prolong the QT interval by blocking I Kr Journal of Cardiovascular Pharmacology and Therapeutics. 17: 102-109. PMID 21317414 DOI: 10.1177/1074248410395020 |
0.783 |
|
2012 |
Pilote S, Patoine D, Simard C, Drolet B. 469 Fingolimod (Gilenya®), a New Oral Treatment for Relapsing Forms of Multiple Sclerosis, Causes Bradycardia and Prolongs the QTC Interval Canadian Journal of Cardiology. 28. DOI: 10.1016/J.Cjca.2012.07.431 |
0.3 |
|
2011 |
Hreiche R, Plante I, Drolet B, Morissette P, Turgeon J. Lengthening of cardiac repolarization in isolated guinea pigs hearts by sequential or concomitant administration of two IKr blockers Journal of Pharmaceutical Sciences. 100: 2469-2481. PMID 21491454 DOI: 10.1002/Jps.22437 |
0.564 |
|
2011 |
Patoine D, Hasibu I, Pilote S, Champagne J, Drolet B, Simard C. A novel KCNQ1 variant (L203P) associated with torsades de pointes-related syncope in a steinert syndrome patient Canadian Journal of Cardiology. 27. PMID 21459285 DOI: 10.1016/J.Cjca.2010.12.045 |
0.329 |
|
2011 |
Vigneault P, Kaddar N, Bourgault S, Caillier B, Pilote S, Patoine D, Simard C, Drolet B. Prolongation of cardiac ventricular repolarization under paliperidone: how and how much? Journal of Cardiovascular Pharmacology. 57: 690-5. PMID 21394035 DOI: 10.1097/Fjc.0B013E318217D941 |
0.744 |
|
2009 |
Hreiche R, Plante I, David LP, Simard C, Turgeon J, Drolet B. Impact of glucose concentration on cardiac ventricular repolarization under IKr/IKs blocking agents Journal of Molecular and Cellular Cardiology. 47: 210-220. PMID 19233195 DOI: 10.1016/J.Yjmcc.2009.02.004 |
0.489 |
|
2007 |
Champagne J, Philippon F, Gilbert M, Molin F, Blier L, Nault I, Sarrazin JF, Charbonneau L, Dufort L, Drolet B, Chahine M, O'Hara GE. The Brugada syndrome in Canada: a unique French-Canadian experience. The Canadian Journal of Cardiology. 23: 71B-75B. PMID 17932591 DOI: 10.1016/S0828-282X(07)71014-0 |
0.426 |
|
2007 |
Drolet B, Simard C, Gailis L, Daleau P. Ischemic, genetic and pharmacological origins of cardiac arrhythmias: The contribution of the Quebec Heart Institute Canadian Journal of Cardiology. 23. PMID 17932583 DOI: 10.1016/S0828-282X(07)71006-1 |
0.559 |
|
2006 |
Plante I, Fournier D, Ricard G, Drolet B, O'Hara G, Champagne J, Mathieu P, Baillot R, Daleau P. Electrophysiological characterization of three non-synonymous single nucleotide polymorphisms (R87Q, A251T, and P307S) found in hKv1.5. PflüGers Archiv : European Journal of Physiology. 452: 316-23. PMID 16411137 DOI: 10.1007/S00424-005-0031-8 |
0.332 |
|
2005 |
Simard C, Drolet B, Yang P, Kim RB, Roden DM. Polymorphism screening in the cardiac K+ channel gene KCNA5. Clinical Pharmacology and Therapeutics. 77: 138-44. PMID 15735608 DOI: 10.1016/j.clpt.2004.10.008 |
0.312 |
|
2004 |
Drolet B, Simard C, Roden DM. Unusual Effects of a QT-Prolonging Drug, Arsenic Trioxide, on Cardiac Potassium Currents Circulation. 109: 26-29. PMID 14691044 DOI: 10.1161/01.CIR.0000109484.00668.CE |
0.528 |
|
2003 |
Drolet B, Yang T, Daleau P, Roden DM, Turgeon J. Risperidone prolongs cardiac repolarization by blocking the rapid component of the delayed rectifier potassium current Journal of Cardiovascular Pharmacology. 41: 934-937. PMID 12775973 DOI: 10.1097/00005344-200306000-00016 |
0.552 |
|
2001 |
Drolet B, Rousseau G, Daleau P, Cardinal R, Simard C, Turgeon J. Pimozide (orap®) prolongs cardiac repolarization by blocking the rapid component of the delayed rectifier potassium current in native cardiac myocytes Journal of Cardiovascular Pharmacology and Therapeutics. 6: 255-260. PMID 11584332 DOI: 10.1177/107424840100600306 |
0.656 |
|
2000 |
Drolet B, Emond A, Fortin V, Daleau P, Rousseau G, Cardinal R, Turgeon J. Vitamin K modulates cardiac action potential by blocking sodium and potassium ion channels Journal of Cardiovascular Pharmacology and Therapeutics. 5: 267-273. PMID 11150396 DOI: 10.1054/Jcpt.2000.16708 |
0.435 |
|
2000 |
Drolet B, Rousseau G, Daleau P, Cardinal R, Turgeon J. Domperidone should not be considered a no-risk alternative to cisapride in the treatment of gastrointestinal motility disorders Circulation. 102: 1883-1885. PMID 11034933 DOI: 10.1161/01.Cir.102.16.1883 |
0.575 |
|
2000 |
Geelen P, Drolet B, Rail J, Bérubé J, Daleau P, Rousseau G, Cardinal R, O'Hara GE, Turgeon J. Sildenafil (viagra) prolongs cardiac repolarization by blocking the rapid component of the delayed rectifier potassium current Circulation. 102: 275-277. PMID 10899088 DOI: 10.1161/01.Cir.102.3.275 |
0.659 |
|
1999 |
Geelen P, Drolet B, Lessard E, Gilbert P, O'Hara GE, Turgeon J. Concomitant Block of the Rapid (IKr) and Slow (IKs) Components of the Delayed Rectifier Potassium Current is Associated With Additional Drug Effects on Lengthening of Cardiac Repolarization Journal of Cardiovascular Pharmacology and Therapeutics. 4: 143-150. PMID 10684535 DOI: 10.1177/107424849900400303 |
0.62 |
|
1999 |
Drolet B, Zhang S, Deschênes D, Rail J, Nadeau S, Zhou Z, January CT, Turgeon J. Droperidol lengthens cardiac repolarization due to block of the rapid component of the delayed rectifier potassium current Journal of Cardiovascular Electrophysiology. 10: 1597-1604. PMID 10636190 DOI: 10.1111/J.1540-8167.1999.Tb00224.X |
0.577 |
|
1998 |
Drolet B, Khalifa M, Daleau P, Hamelin BA, Turgeon J. Block of the Rapid Component of the Delayed Rectifier Potassium Current by the Prokinetic Agent Cisapride Underlies Drug-Related Lengthening of the QT Interval Circulation. 97: 204-210. PMID 9445174 DOI: 10.1161/01.Cir.97.2.204 |
0.583 |
|
Show low-probability matches. |